AirLogix

AirLogix was a specialized healthcare company focused on disease management programs for chronic respiratory conditions, primarily asthma and Chronic Obstructive Pulmonary Disease (COPD). The company provided clinical intervention programs designed to improve patient outcomes and reduce healthcare costs for managed care organizations and self-insured employers. By utilizing evidence-based protocols and patient monitoring, AirLogix helped patients better manage their conditions and avoid emergency room visits. In 2003, the company was acquired by Caremark Rx to enhance its therapeutic portfolio and disease management capabilities.